[go: up one dir, main page]

ES2139744T3 - Sintesis estereoselectiva de analogos de nucleosidos empleando un intermediario biciclico. - Google Patents

Sintesis estereoselectiva de analogos de nucleosidos empleando un intermediario biciclico.

Info

Publication number
ES2139744T3
ES2139744T3 ES94918252T ES94918252T ES2139744T3 ES 2139744 T3 ES2139744 T3 ES 2139744T3 ES 94918252 T ES94918252 T ES 94918252T ES 94918252 T ES94918252 T ES 94918252T ES 2139744 T3 ES2139744 T3 ES 2139744T3
Authority
ES
Spain
Prior art keywords
bicycle
intermediary
stereoselective synthesis
nucleosid
analogs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94918252T
Other languages
English (en)
Inventor
Tarek S Mansour
Colleen A Evans
Haolun Jin
Arshad M Siddiqui
Allan H L Tse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shire Canada Inc
Original Assignee
IAF BioChem International Inc
Biochem Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IAF BioChem International Inc, Biochem Pharma Inc filed Critical IAF BioChem International Inc
Application granted granted Critical
Publication of ES2139744T3 publication Critical patent/ES2139744T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D411/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D497/00Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/08Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA INVENCION SE REFIERE A UN PROCESO PARA PRODUCIR ANALOGOS DE NUCLEOSIDOS CIS PREDOMINANTEMENTE PUROS UTILIZANDO UN NUEVO COMPUESTO INTERMEDIO BICICLICO DE LA FORMULA (III), EN LA X ES S, U O; Y ES S, CH2, O O CH(R); EN DONDE R ES AZIDO O HALOGENO, Y Z ES S U O.
ES94918252T 1993-06-07 1994-06-07 Sintesis estereoselectiva de analogos de nucleosidos empleando un intermediario biciclico. Expired - Lifetime ES2139744T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939311709A GB9311709D0 (en) 1993-06-07 1993-06-07 Stereoselective synthesis of nucleoside analogues using bicycle intermediate

Publications (1)

Publication Number Publication Date
ES2139744T3 true ES2139744T3 (es) 2000-02-16

Family

ID=10736757

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94918252T Expired - Lifetime ES2139744T3 (es) 1993-06-07 1994-06-07 Sintesis estereoselectiva de analogos de nucleosidos empleando un intermediario biciclico.

Country Status (21)

Country Link
US (1) US5763606A (es)
EP (1) EP0654031B1 (es)
JP (1) JP3110461B2 (es)
KR (1) KR100304072B1 (es)
CN (1) CN1046720C (es)
AT (1) ATE188215T1 (es)
AU (1) AU668829B2 (es)
BR (1) BR9405423A (es)
CA (1) CA2141029C (es)
DE (1) DE69422374T2 (es)
DK (1) DK0654031T3 (es)
ES (1) ES2139744T3 (es)
FI (1) FI112078B (es)
GB (1) GB9311709D0 (es)
HU (1) HU219199B (es)
NO (1) NO303449B1 (es)
NZ (1) NZ267379A (es)
OA (1) OA10349A (es)
PL (1) PL180870B1 (es)
RU (1) RU2139870C1 (es)
WO (1) WO1994029301A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6175008B1 (en) * 1988-04-11 2001-01-16 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
AU3710395A (en) * 1994-10-22 1996-05-15 Chong Kun Dang Corporation Nucleoside derivatives and process for preparing thereof
ES2232169T3 (es) 1998-08-12 2005-05-16 Gilead Sciences, Inc. Procedimiento de fabricacion de nucleosidos de 1,3-oxatiolano.
US6979561B1 (en) 1998-10-09 2005-12-27 Gilead Sciences, Inc. Non-homogeneous systems for the resolution of enantiomeric mixtures
CA2308559C (en) 2000-05-16 2005-07-26 Brantford Chemicals Inc. 1,3-oxathiolan-5-ones useful in the production of antiviral nucleoside analogues
ATE312097T1 (de) 2001-03-01 2005-12-15 Gilead Sciences Inc Polymorphe und andere kristalline formen von cis- ftc
ATE398455T1 (de) 2003-01-14 2008-07-15 Gilead Sciences Inc Zusammensetzungen und verfahren zur antiviralen kombinationstherapie
WO2005074654A2 (en) 2004-02-03 2005-08-18 Emory University Methods to manufacture 1,3-dioxolane nucleosides
TWI375560B (en) 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5204466A (en) * 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
GB9009861D0 (en) * 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
AU9125991A (en) * 1990-12-05 1992-07-08 University Of Georgia Research Foundation, Inc., The Enantiomerically pure beta -l-(-)-1,3-oxathiolane nucleosides
ZA923640B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
GB9116601D0 (en) * 1991-08-01 1991-09-18 Iaf Biochem Int 1,3-oxathiolane nucleoside analogues
US5332814A (en) * 1991-11-12 1994-07-26 Ciba-Geigy Corporation Process for the preparation of carbacyclic nucleosides, and intermediates

Also Published As

Publication number Publication date
WO1994029301A1 (en) 1994-12-22
GB9311709D0 (en) 1993-07-21
EP0654031A1 (en) 1995-05-24
HU9500364D0 (en) 1995-05-29
DK0654031T3 (da) 2000-06-13
AU668829B2 (en) 1996-05-16
FI950535A0 (fi) 1995-02-07
AU6966794A (en) 1995-01-03
KR100304072B1 (ko) 2001-11-22
CN1110479A (zh) 1995-10-18
DE69422374D1 (de) 2000-02-03
CN1046720C (zh) 1999-11-24
RU95108553A (ru) 1996-11-20
NO950432L (no) 1995-03-13
PL307350A1 (en) 1995-05-15
OA10349A (en) 2001-10-18
BR9405423A (pt) 1999-05-25
FI112078B (fi) 2003-10-31
JP3110461B2 (ja) 2000-11-20
CA2141029C (en) 2000-07-25
US5763606A (en) 1998-06-09
NO950432D0 (no) 1995-02-06
RU2139870C1 (ru) 1999-10-20
DE69422374T2 (de) 2000-06-29
CA2141029A1 (en) 1994-12-22
PL180870B1 (pl) 2001-04-30
FI950535L (fi) 1995-02-07
ATE188215T1 (de) 2000-01-15
HU219199B (en) 2001-03-28
EP0654031B1 (en) 1999-12-29
NO303449B1 (no) 1998-07-13
HUT73630A (en) 1996-08-28
JPH08505643A (ja) 1996-06-18
HK1008673A1 (en) 1999-05-14
NZ267379A (en) 1997-04-24

Similar Documents

Publication Publication Date Title
GR3024420T3 (en) Process for the preparation of oxetanones
DK0582790T3 (da) Ny fremgangsmåde til fremstilling af 7-substituerede-9-[(substitueret glycyl)-amino]-6-demethyl-6-deoxytetracycliner
DK0592435T3 (da) Fremgangsmåde til fremstilling af pyrimidinforbindelser
ES2139744T3 (es) Sintesis estereoselectiva de analogos de nucleosidos empleando un intermediario biciclico.
SE9701593D0 (sv) Nitrerstål
DK0956033T3 (da) Totalsyntese af amino-Hip-analogen af didemnin A
CA2065008A1 (en) Light Activated Acyl-Enzymes
DK1255747T3 (da) Syntese af 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-on
DK1127886T3 (da) Syntese af 3,6-dialkyl-5,6-dihydro-4-hydroxy-2H-pyran-2-on
HUT74942A (en) New conversion of bisnoralcohol to bisnoraldehyde
HU9400020D0 (en) New process for producing sulphur-derivatives of imidazole, and the obtained new intermediates
NO940113L (no) Syntese av 2-fenyl-substituerte 1,3-propandioler
DE69430259D1 (de) Neuer kalium-kanal-agonist, der von trichoderma virens gewonnen wird
IL74269A0 (en) 2-alkoxyaminosulfonylbenzene-sulfonylureas,their production and their use as herbicides
MX9603450A (es) Procedimiento para la obtencion de aminotriazolinas substituidas.
DK0492350T3 (da) Fremgangsmåde til fremstilling af (S)-vinyl- og (S)-allenyl-GABA
HU9300462D0 (en) New anti-viral compounds and method for producing them
DK0705273T3 (da) 17-Halogen-4-azaandrostenderivater og fremgangsmåde til fremstilling af sådanne
MX9702486A (es) La fabricacion de levobupivacaina y sus analogos de l-lisina.
IT1203879B (it) Procedimento per la preparazione di (+)-13-norfaranale
SI0690848T1 (en) Piperazinylpyridinyl water clathrates
AR005042A1 (es) Procedimiento para la preparacion de un antagonista endotelin.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 654031

Country of ref document: ES